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Abstract
Aims To survey the perceived indications for magnetic reso-
nance imaging of the small bowel (MRE) by experts, when
MR enteroclysis (MREc) or MR enterography (MREg) may
be chosen, and to determine how the approach to MRE is
modified when general anaesthesia (GA) is required.
Materials and methods Selected opinion leaders in MRE
completed a questionnaire that included clinical indications
(MREg or MREc), specifics regarding administration
of enteral contrast, and how the technique is altered to
accommodate GA.
Results Fourteen responded. Only the diagnosis and follow-up
of Crohn’s disease were considered by over 80 % as a valid
MRE indication. The remaining indications ranged between
35.7 % for diagnosis of caeliac disease and unknown sources
of gastrointestinal bleeding to 78.6 % for motility disorders.
Themajority choseMREg overMREc for all indications (from
100 % for follow-up of caeliac disease to 57.7 % for tumour
diagnosis). Fifty per cent of responders had needed to consider
MRE under GA. The most commonly recommended proce-
dural change was MRI without enteral distention. Three had
experience with intubation under GA (MREc modification).
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Conclusion Views were variable. Requests for MRE under
GA are not uncommon. Presently most opinion leaders sug-
gest standard abdominal MRI when GA is required.
Main messages
• Experts are using MRE for various indications.
• Requests for MRE under general anaesthesia are not
uncommon.
• Some radiologists employ MREc under general anaesthesia;
others do not distend the small bowel.




ECCO European Crohn’s and Colitis Organisation
EL Evidence level
ESGAR European Society of Gastrointestinal and
Abdominal Radiology
GA General anaesthesia
MRE Magnetic resonance imaging of small bowel
MREc Magnetic resonance imaging performed by
means of enteroclysis
MREg Magnetic resonance imaging performed by means
of oral intake (or nasogastric tube), also called
enterography follow-through or hydro-MRI




In a recent evidence-based consensus for assessment of small
bowel (SB) inflammatory disease [1] jointly from the Europe-
an Crohn’s and Colitis Organisation (ECCO) and European
Society of Gastrointestinal and Abdominal Radiology
(ESGAR), it was stated that (abbreviation added to suit our
article): BMagnetic resonance imaging (MRI) of the small
bowel (MRE) and colon requires fast imaging techniques
and luminal distension [Evidence Level (EL) 2]. MRE has
similar diagnostic accuracy and similar indications to CT,
but with the major advantage of not imparting ionising
radiation [EL 1]^.
While most radiologists recommend distention for ade-
quate SB assessment, methods to achieve this vary. Some
use enterography (oral administration) or enteroclysis
(nasojejunal intubation with the tube tip in close proximity
to the ligament of Treitz). Improved capability of MRI to
diagnose SB pathology has generated increasing requests to
perform these examinations in patients who require general
anaesthesia (GA). Demand is particularly increasing in the
paediatric age group, not least in an attempt to limit exposure
to ionising radiation. SB distension with large volumes of
orally administered fluids, however, is generally considered
a contraindication in GA, or heavy sedation, given the risk
of aspiration [2–5]. To deliberately distend the SB with fluids
would, therefore, be contradictory to this general rule.
To date there are no published data on the safety or other-
wise of performingMRE under GA, nor is there any guidance
on any required protocol modifications.
The purposes of this study were to:
1. Survey key opinion leaders regarding their current indica-
tions and protocols for undertaking MRE.
2. To document their attitudes and experience of performing
MRE under GA in order to issue guidance for this specific
clinical scenario.
Materials and methods
Two radiologists (MRT and TL) devised the questionnaire,
which covered four broad topic areas addressed by a series
of multiple choice questions, together with space for free
comments.
The questionnaire was sent to recognised opinion leaders,
chosen via a history of prior indexed publications, supple-
mented by the chief investigators personal knowledge of their
work and contributions in the field. Twenty-four radiologists
were identified initially and each contacted on up to three
occasions for an initial response with a goal to recruit at least
ten completed responses. If responses were incomplete, par-
ticipants were again contacted. The topic areas addressed were
as follows:
Part I (questions 1–12): The first topic covered the num-
ber of examinations performed annually and the imaging
modality of choice for named different pathologies with
an emphasis on magnetic resonance enterography
(MREg) vs. magnetic resonance enteroclysis (MREc).
Part II (questions 13–20): The preference(s) of opinion
leaders for SB distension including type of contrast agent,
desired signal characteristics, and mode and rate of
administration.
Part III (questions 21–25): Experience with MRI under
GAwas canvassed including any changes in indications
in comparison to routine MRE. Specifically experts were
asked if they favored MRI without SB distension, instead
of MRE when GAwas required, and whether they would
rather choose an alternative modality (e.g. CT).
Part IV (questions 26–39): These related to protocol mod-
ifications made by experts if they performed SB MRI
under GA.
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The results were entered in Excel file sheets and expressed
as percentages of the responses.
Results
Fourteen experts completed the questionnaire. Two of the in-
vitees were not radiologists and chose not to participate, and
two others mentioned that they were working at the same
institution as the responding 14 and wanted to avoid duplica-
tion. The other six invitees did not respond. Among the re-
sponders, all interpreted between 100 and 500 small bowel
MRIs annually, averaging 222.
Part I
All experts (14 out of 14 or 100 %) advocate MRI for follow-
up of SB Crohn’s disease with most advocatingMREg (13 out
of 14, 93 %) as opposed to MREc (1 out of 14, Fig. 1). The
majority usedMRI to confirm/refute an initial diagnosis of SB
Crohn’s disease with 93 % (13 out of 14) choosing MRE (of
whom 11 or 79 % chose MREg).
For studying SB motility disorders 79 % (11 out of 14)
chose MRE (10 out of 14 or 71 % MREg).
The most frequent indications where MRE (MREg or
MREc) was not chosen by the majority of experts as the
imaging modality of choice were (followed by the proportion
who preferred other radiologic and non-radiologic methods of
valuation): the evaluation of serosal tumour implants (10 out
of 14 or 71 %), diagnosis of caeliac disease (9 out of 14 or
64 %), unknown source of gastrointestinal bleeding after
negative colonoscopy and gastroduodenoscopy (9 out of 14
or 64%), and follow-up (8 out of 14 or 57%) and diagnosis (7
out of 14 or 50 %) of SB tumours (Fig. 1). In all the other
conditions, as mentioned in Fig. 1, MRE was preferred.
Interestingly, MREg was always more frequently favoured
than MREc, between 0 % (follow-up of caeliac disease with
MREc and MREg favoured by none and 8 experts,
respectively) to 43 % (diagnosis of small bowel tumours with
MREc and MREg favoured by 3 and 4 experts, respectively).
Part II
Position of the patient
The prone position was clearly favoured (12 experts out of 14
or 86 %), with supine positioning as second (2 experts out of
14 or 14 %).
Type of oral contrast agent
Among the contrast agents specified, mannitol was the most
common among the experts (4 experts out of 14 or 29 %),
followed by VoLumen (3 experts out of 14 or 21 %), sorbitol
(2 experts out of 14 or 14 %) and tap water by one expert (1
out of 14 or 7 %). Four experts chose other contrast agents
[locust bean gum (LBG) by two researchers and polyethylene
glycol solution (PEG) and Glycoprep-C at one centre each].
The most common feature among all experts was their choice
of contrast agents that had the signal characteristics of water,
i.e. double phasic being high signal on T2 weighting and low
signal on T1 weighting.
Fig. 1 The choice of
examinations by different experts
for different diseases. Blue bars:
MREc or MR enterlocysis; red
bar: MREg or MR enterography;
yellow bar: other free choices of
both radiological imaging
methods or any other possible
means
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Factors influencing the rate and volume of the administered
contrast agent
The volume of oral agent ingested during MREg was influ-
enced primarily by patient compliance, even though a fixed
volume was planned to be given at the start of the procedure.
The time allowed for ingestion was always fixed and thus it
was the rate of administration that resulted in the differences in
administered oral agent volumes. For MREc, monitoring pro-
gression of the contrast agent with a fixed rate seemed to be
most influential in the determination of the administration rate
(Figs. 2 and 3).
Part III
MRI under GAwas performed only at 8 out of 14 (57 %) of
the centres. In half of the centres with (4 out of 14) and half of
those without (3 out of 14), the possibility of MRI under GA
had led to the request to perform MRE under GA.
When asked to do MRE under GA 3 out of 14 (21 %)
experts did not recommend MRI (Fig. 4). Eight experts out
of 14 (57 %), however, would perform standard abdominal
MRI (4 out of 14 or 29 %), e.g. with no SB distension or
choosing some form of intubation (4 out of 14 or 29 %).
Intubation would be done either as an MREc alone or an
MREc with the addition of a stomach tube to drain excessive
stomach fluid. Three experts perform MRE under GA.
Part IV
This section dealt with modifications employed if there was a
question of combining MRE with a GA. Most cases where
GA is requested are young children who cannot comply with
the examination. However there are some patients who require
GA because of impaired cognitive function or mental retarda-
tion. Patient age has an important role. The number of experts
employing prone positioning decreased to 6 out of 14 (41 %),
3 choosing supine, 3 choosing whatever position was easiest
for the anaesthesiologist and one choosing right decubitus. It
should be considered that a supine patient is in the most con-
venient position for the anaesthesiologist unless specific is-
sues warrant other positions.
An almost equal number of experts, 4 out of 14 (27 %) and
3 out of 14 (36 %), employed endoscopic methods and/or
fluoroscopy for nasojejunal tube insertion if enteroclysis
would be employed under these circumstances, respectively.
Of the experts questioned only three had first-hand experi-
ence with MRE under GA (initials blinded). Most of the dif-
ferences in their protocols are related to differences in MREc in
general. The major differences among the authors that are re-
lated to MREc being done under GA is the use of one tube (n=
2 participants) or two tubes (n=1 participant) method. The
latter participant tries to combine upper gastrointestinal endos-
copy under GA (which patients usually need for various rea-
sons) withMREc under GA. The endoscopist inserts both tubes
with the tip in the stomach, and the radiologist then advances
one tube to its position at the level of the Treitz ligament. He or
she uses two nasogastric tubes for drainage of any regurgitated
fluids from the intestines into the stomach during MRE.
Discussion
This survey illustrates a degree of discrepancy among experts
performing MRE. Considering the proportion agreeing on a
valid indication for MRE, only two indications exceeded
Fig. 2 Factors influencing the
volume of enteral contrast agents.
Blue bars: MREc or MR
enterlocysis; red bar: MREg or
MR enterography
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80 %: the initial diagnosis and follow-up of Crohn’s disease
[6–18]. Otherwise, we observed a wide variation among our
experts regarding other indications for MRE. These ranged
from 29 % suggesting MRE for evaluation of serosal carcino-
matosis (oral presentation at the European Congress of Radi-
ology 2014 by MRT) and ischaemia [19] to 79 % for motility
studies [20–29].
Such variation in opinion and perceived indications may
depend on the wide experimental potential for MRE as well as
the academic orientation of our experts. These experts are
more known for their research and inclined to test new appli-
cations. Experience may also contribute to variation in the
responses we observed [30, 31]. Small bowel diseases are
varied, many are relatively uncommon, and it is time-
consuming for each research group to accrue sufficient num-
bers of cases and report them, and for other researchers to
confirm the initial observations. Only Crohn’s disease has
been studied in large numbers and by many individuals and
Fig. 3 Factors influencing the
rate of administration of enteral
agent. Blue bars: MREc or MR
enterlocysis; red bar: MREg or
MR enterography
Fig. 4 Change in methodology
in the number of experts when
confronted with the dilemma of
doing MRI under general
anaesthesia. Green bar: MRE is
not the best alternative (among
those with access to MRI under
general anaesthesia). Yellow bar:
MRE is not the best alternative
(among those with or without
access to MRI under GA). Blue
bar: distention is not essential and
therefore MRI of the abdomen is
sufficient. Red bar: how
participant answered to
indications for MRE in part I
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groups. Oftentimes CT of the small intestine is preferred to
MRE because of the availability and lower cost. MRE, how-
ever, offers diagnostic advantages in addition to a lack of
ionising radiation, and MRE can also be performed without
intravenous contrast agents if there is renal insufficiency [32].
We did not focus on the technique and imaging sequences
required for MRE, which deserves a separate study. The
amount of enteral agent [33], its timing [34], osmolarity
[35], type of agent [36, 37], its concentration [38], type of
antiperistaltic agent [39, 40], additives such as erythromycin
and enema [41], MRI sequences used [42, 43] and field
strength [44] are just some possible modifications. Unfortu-
nately most if not all protocol modifications have been under-
taken on healthy volunteers. Some areas have not been
touched. One area specifically not covered was administration
of intravenous contrast agents as this was not expected to
change because of GA. The authors had been asked to men-
tion what parts of the protocol they would change if
performing MRE under GA. Colon distention, though shown
to improve small bowel distention, is rarely used. Further-
more, employing an enema in an unconscious patient inside
an MR machine is probably never used. Nonetheless no one
reported enema administration when asked about protocol
modifications due to patients undergoing GA. Among the
questions we posed, there was no single factor that was con-
sidered by at least 80 % of our experts as important for deter-
mining the volume and/or rate of the agent administered. The
factors that the experts agreed upon were that the signal char-
acteristic of the agent was biphasic, behaving like water, and
that the patient was examined prone.
We, however, focused more on the choice between MREc
andMREg as this has been more controversial and more stud-
ied, albeit only in patients with Crohn’s disease [45, 46]. In
brief patients prefer MREg [46], while radiologists prefer
MREc images [46–50]. MREc probably demonstrates more
superficial ulcerations than MREg [18]. The joint position
statement from ECCO and ESGAR also considered
enteroclysis as likely better for the diagnosis of partial small
bowel obstruction in Crohn’s disease [2], though no statisti-
cally significant advantage was evident in the studies refer-
enced [50]. For other patients, such as those withmalignancies
or gastrointestinal bleeding, every tumour site is important.
This is probably reflected in higher proportions of our experts
choosing MREc than any other indication, though still less
than MREg. Studies such as that from Gupta et al. [51] with
MREg have shown such good results that one can understand
why experts prefer MREg. In this particular study, recruiting
patients with Peutz-Jeghers syndrome, patients preferred cap-
sule endoscopy over MREg and one might speculate that this
preference would be more exaggerated if MREc had been
offered.
Half of our experts had been exposed to the scenario of
MRE under GA, an observation regardless of whether MRI
under GA was available at their own centre. Most experts
when confronted with this dilemma still opted for MRI, but
used a standard approach. This choice suggests that MRI is
such a powerful method that most experts still consider it
advantageous to do MRI as opposed to choosing another
modality.
The change in methods due to GA can be based on two
aspects. One is that MRI may not be much better than other
available methods (e.g. CT) that could easily replace MRI.
The other is that SB distention is not important and the risk
of SB distention outweighs any potential benefits. In some
cases such as unknown GI bleeding no one would risk MRI
with, or without, SB distention as the first choice. For diagno-
sis and follow-up of SB Crohn’s disease and motility distur-
bances, however, there are some who consider that the bene-
fits of MRI outweigh its risk. Our study demonstrates that the
widespread use of MRE has led to requests for it in patients
who otherwise require GA under anaesthesia. Considering the
risks associated with GA, therefore, it seems prudent to em-
ploy other available modalities such as CT if the benefit from
MRI does not justify the risk of GA. If the benefit of MRI
seems to outweigh the risk of GA, then a decision must be
made on how valuable the distention is. Finally, if distention is
required and MRE is employed, then based on the experience
of radiologists in this study, MREc is the preferred method,
avoiding major filling of the stomach and having more control
over gastric filling (perhaps via a separate gastric tube).
Our study has several shortcomings. First, the selection
process of the experts could be questioned, i.e. who qualifies
as an expert. Most of our researchers are from the Western
hemisphere and Australia. Clearly they have more experience
with Crohn’s disease than certain other diseases, e.g. small
bowel tuberculosis. Despite this, the variation in responses
was so striking that we expect that with the inclusion of more
international experts with more heterogeneous backgrounds
this variation would only become even more prominent. Sec-
ond, it has become common practice to use the Delphi pro-
cess, or similar approaches, for examining agreement among
experts. Our main concern was centred on MRE under GA
and other areas were touched on only briefly. For many po-
tential indications there are no existing publications in the
available literature and so the Delphi process (or its modifica-
tions) and/or systematic review and meta-analysis are
impossible.
Conclusion
Most experts clearly prefer MREg over MREc. There are
many emerging indications for MRE. When confronted by
the prospects of performing MRE under GA many experts
would still do MRI with or without small bowel distention
rather than choosing another modality. This article, however,
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demonstrates that more work is needed to address the funda-
mental issues concerningMRE.MRE is usually performed by
a few enthusiastic individuals working at separate centres and
there is a need for more collaborative work putting the ideas
and experiences of these individuals together.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
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